Key Details
Annual EPS
-$0.07Annual ROE
1364.32%Beta
-Events Calendar
Next earnings date:
N/ARecent quarterly earnings:
Aug 15, 2023Recent annual earnings:
Mar 30, 2020Next ex-dividend date:
N/ARecent ex-dividend date:
N/ANext split:
N/ARecent split:
N/AAnalyst ratings
Recent major analysts updates
No data about analysts updates
Screeners with NYMX included
No data
Market Data
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Dividend
Nymox Pharmaceutical doesn't have historical dividend data
Profitability
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Efficiency
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Valuation
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Liquidity
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Cash Flow
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Institutional Ownership
Similar stocks
Why Is Nymox Pharmaceutical (NYMX) Stock Down 18% Today?
NYMX
InvestorPlace06 July 2023
Nymox Pharmaceutical (NASDAQ: NYMX ) stock is falling on Thursday after the company told investors its shares will be delisted. Shares of NYMX stock will no longer trade on the Nasdaq Exchange when markets open on Friday.
FAQ
- What is the primary business of Nymox Pharmaceutical?
- What is the ticker symbol for Nymox Pharmaceutical?
- Does Nymox Pharmaceutical pay dividends?
- What sector is Nymox Pharmaceutical in?
- What industry is Nymox Pharmaceutical in?
- What country is Nymox Pharmaceutical based in?
- When did Nymox Pharmaceutical go public?
- Is Nymox Pharmaceutical in the S&P 500?
- Is Nymox Pharmaceutical in the NASDAQ 100?
- Is Nymox Pharmaceutical in the Dow Jones?
- When was Nymox Pharmaceutical's last earnings report?
- When does Nymox Pharmaceutical report earnings?
What is the primary business of Nymox Pharmaceutical?
Nymox Pharmaceutical Corporation, a biopharmaceutical company, engages in the research and development of drugs for the aging population in Canada, the United States, Europe, and internationally. Its lead drug candidate is Fexapotide Triflutate (NX-1207), which is in various clinical trials for the treatment of benign prostatic hyperplasia and low grade localized prostate cancer, as well as is in preclinical studies for hepatocellular carcinoma. The company also develops and markets NicAlert for detecting tobacco product usage; and TobacAlert for detecting second-hand smoke exposure. In addition, it develops drugs for the treatment of Alzheimer's disease. Nymox Pharmaceutical Corporation was founded in 1989 and is headquartered in Nassau, the Bahamas.
What is the ticker symbol for Nymox Pharmaceutical?
The ticker symbol for Nymox Pharmaceutical is NASDAQ:NYMX
Does Nymox Pharmaceutical pay dividends?
No, Nymox Pharmaceutical does not pay dividends
What sector is Nymox Pharmaceutical in?
Nymox Pharmaceutical is in the Healthcare sector
What industry is Nymox Pharmaceutical in?
Nymox Pharmaceutical is in the Biotechnology industry
What country is Nymox Pharmaceutical based in?
Nymox Pharmaceutical is headquartered in Bahamas
When did Nymox Pharmaceutical go public?
Nymox Pharmaceutical's initial public offering (IPO) was on 26 November 1997
Is Nymox Pharmaceutical in the S&P 500?
No, Nymox Pharmaceutical is not included in the S&P 500 index
Is Nymox Pharmaceutical in the NASDAQ 100?
No, Nymox Pharmaceutical is not included in the NASDAQ 100 index
Is Nymox Pharmaceutical in the Dow Jones?
No, Nymox Pharmaceutical is not included in the Dow Jones index
When was Nymox Pharmaceutical's last earnings report?
Nymox Pharmaceutical's most recent earnings report was on 15 August 2023
When does Nymox Pharmaceutical report earnings?
The date for Nymox Pharmaceutical's next earnings report has not been announced yet